share_log

藥明巨諾-B：董事會會議通告

JW THERAP-B: NOTICE OF BOARD MEETING

HKEX ·  Aug 14 16:36

Summary by Futu AI

藥明巨諾-B（開曼）有限公司宣布將於2024年8月28日舉行董事會會議，主要目的是考慮及批准該集團截至2024年6月30日止六個月的未經審核中期業績及其發佈。會議將由主席Yiping James Li（李怡平）醫生主持，並將處理任何其他事項。該通告由藥明巨諾-B於2024年8月14日發佈。
藥明巨諾-B（開曼）有限公司宣布將於2024年8月28日舉行董事會會議，主要目的是考慮及批准該集團截至2024年6月30日止六個月的未經審核中期業績及其發佈。會議將由主席Yiping James Li（李怡平）醫生主持，並將處理任何其他事項。該通告由藥明巨諾-B於2024年8月14日發佈。
WuXi Biologics (Cayman) Inc. announced that it will hold a Board of Directors meeting on August 28, 2024 to consider and approve the unaudited interim results of the group for the six months ended June 30, 2024. The meeting will be chaired by Dr. Yiping James Li and will address any other matters. This announcement was released by WuXi Biologics (Cayman) Inc. on August 14, 2024.
WuXi Biologics (Cayman) Inc. announced that it will hold a Board of Directors meeting on August 28, 2024 to consider and approve the unaudited interim results of the group for the six months ended June 30, 2024. The meeting will be chaired by Dr. Yiping James Li and will address any other matters. This announcement was released by WuXi Biologics (Cayman) Inc. on August 14, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated